Planta Med 2011; 77(14): 1663-1667
DOI: 10.1055/s-0030-1270932
Biological Screening
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

In vitro Screening of Traditional South African Malaria Remedies against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and Plasmodium falciparum

Tsholofelo A. Mokoka1 , Stefanie Zimmermann2 , 3 , Tasqiah Julianti2 , 5 , Yoshie Hata2 , 6 , Nivan Moodley1 , Monica Cal3 , Michael Adams2 , Marcel Kaiser3 , Reto Brun3 , Neil Koorbanally4 , Matthias Hamburger2
  • 1Biosciences, CSIR, Pretoria, South Africa
  • 2Institute of Pharmaceutical Biology, University of Basel, Basel, Switzerland
  • 3Swiss Tropical and Public Health Institute, Basel, Switzerland
  • 4School of Chemistry, University of KwaZulu-Natal, Durban, South Africa
  • 5Faculty of Pharmacy, Pancasila University, Jakarta, Indonesia
  • 6Departamento de Farmacia, Universidad Nacional de Colombia, Bogotá, Colombia
Weitere Informationen

Publikationsverlauf

received January 10, 2011 revised February 24, 2011

accepted February 26, 2011

Publikationsdatum:
16. März 2011 (online)

Preview

Abstract

Three hundred extracts were prepared from plants traditionally used in South Africa to treat malaria and screened in vitro for activity against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and Plasmodium falciparum. For the 43 extracts which inhibited the growth of one or more parasites to more than 95 % at 9.7 µg/mL, the IC50 values against all four protozoal parasites and cytotoxic IC50s against rat myoblast L6 cells were determined. Amongst the most notable results are the activities of Agathosma apiculata (IC50 of 0.3 µg/mL) against Plasmodium falciparum, as well as Salvia repens and Maytenus undata against Leishmania donovani with IC50s of 5.4 µg/mL and 5.6 µg/mL, respectively. This screening is the starting point for a HPLC-based activity profiling project in antiprotozoal lead discovery.

References

Prof. Dr. Matthias Hamburger

Department of Pharmaceutical Sciences
Institute of Pharmaceutical Biology
University of Basel

Klingelbergstrasse 50

4056 Basel

Switzerland

Telefon: +41 6 12 67 15 55

Fax: +41 6 12 67 14 74

eMail: matthias.hamburger@unibas.ch